Strengths of this study include its prospective design, large size,
and the availability of detailed information on aspirin use updated
at several different time points. Because of these strengths,
we could comprehensively examine the association between cancer risk and a relatively well defined,
and potentially clinically usable,
regimen of aspirin use (long-term daily use of adult-strength aspirin)
that has not previously been studied with respect to cancer.